BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sembill JA, Kuramatsu JB, Schwab S, Huttner HB. Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage. Neurol Res Pract 2019;1:12. [PMID: 33324878 DOI: 10.1186/s42466-019-0018-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Shoskes A, Fan TH, Starling RC, Cho S. “Neurologic Complications in Patients with Left Ventricular Assist Devices”. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.11.004] [Reference Citation Analysis]
2 Hacke W. A look back at 3 years of neurological research and practice (NRP). Neurol Res Pract 2022;4:19. [PMID: 35484603 DOI: 10.1186/s42466-022-00182-z] [Reference Citation Analysis]
3 Suryadi T, Kulsum K. Case Report: Case report: Administration of anticoagulant therapy after neuro-anesthesia procedure for hemorrhagic stroke patients with COVID-19 complications and its ethical and medicolegal consideration. F1000Res 2021;10:1303. [DOI: 10.12688/f1000research.75630.1] [Reference Citation Analysis]
4 Sadaf H, Desai VR, Misra V, Golanov E, Hegde ML, Villapol S, Karmonik C, Regnier-Golanov A, Sayenko D, Horner PJ, Krencik R, Weng YL, Vahidy FS, Britz GW. A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage. Ann Clin Transl Neurol 2021;8:2211-21. [PMID: 34647437 DOI: 10.1002/acn3.51443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nobleza COS. Intracerebral Hemorrhage. Continuum (Minneap Minn) 2021;27:1246-77. [PMID: 34618759 DOI: 10.1212/CON.0000000000001018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Abrantes CS, Pintalhão M, Tavares S, Fonseca L, Chaves PC. Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis. Neurol Sci 2021. [PMID: 34542785 DOI: 10.1007/s10072-021-05602-7] [Reference Citation Analysis]
7 Grundtvig J, Ovesen C, Havsteen I, Christensen T, Gaist D, Iversen HK, Kruuse C, Lilja-Cyron A, Ægidius K, Rosenbaum S, Meden P, Marstrand J, Christensen L, Steiner T, Christensen H. Trends in incidence of oral anticoagulant-related intracerebral hemorrhage and sales of oral anticoagulants in Capital Region of Denmark 2010-2017. Eur Stroke J 2021;6:143-50. [PMID: 34414289 DOI: 10.1177/23969873211008770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Xu Y, Siegal DM. Anticoagulant-associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants. J Thromb Haemost 2021. [PMID: 34273241 DOI: 10.1111/jth.15466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dürschmied D, Goette A, Hardt R, Kleinschnitz C, Kämmerer W, Lembens C, Schmitt W, Bode C. [Interdisciplinary aspects of oral anticoagulation with NOACs in atrial fibrillation]. Dtsch Med Wochenschr 2021;146:S2-S16. [PMID: 33957679 DOI: 10.1055/a-1472-3188] [Reference Citation Analysis]
10 Kelly J. New horizons: managing antithrombotic dilemmas in patients with cerebral amyloid angiopathy. Age Ageing 2021;50:347-55. [PMID: 33480964 DOI: 10.1093/ageing/afaa275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Hacke W. Neurological research and practice: the first milestone has been reached. Neurol Res Pract 2021;3:3. [PMID: 33462566 DOI: 10.1186/s42466-021-00101-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hacke W. Neurological research and practice: the first year. Neurol Res Pract 2020;2:5. [PMID: 33324911 DOI: 10.1186/s42466-020-0054-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wang CL, Wu VC, Huang YT, Chen YL, Chu PH, Kuo CF, Wen MS, Chang SH. Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation. J Thromb Thrombolysis 2021;51:58-66. [PMID: 32409936 DOI: 10.1007/s11239-020-02135-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]